How the PBS works for chronic conditions

For anyone managing a long-term health condition, the Pharmaceutical Benefits Scheme is one of the most useful parts of the Australian health system to understand. It’s the reason most prescription medicines have a familiar, predictable price at the counter rather than the much higher commercial cost. But it has rules — and the rules matter, especially for chronic conditions where you’ll be picking up medicines regularly for a long time.

This page covers what the PBS is, how listings work, what changes for chronic conditions, and the practical things worth knowing.

What the PBS is

The PBS is a federal government scheme that subsidises the cost of selected prescription medicines for eligible Australians. It’s been running in some form since the late 1940s and is one of the larger items in the federal health budget.

The simple version is: when a medicine is listed on the PBS for a given indication, the government pays most of the cost, and the patient pays a much smaller co-payment at the pharmacy. The medicine still needs to be prescribed by an authorised prescriber and supplied by a pharmacist — the PBS doesn’t change those steps. It just changes what the patient pays.

How medicines get listed

Adding a medicine to the PBS is a separate process from getting it onto the Australian Register of Therapeutic Goods (the ARTG, which is the regulatory approval to supply a medicine in Australia at all).

A medicine has to be ARTG-registered first. Then the sponsor — the company that makes or distributes the medicine — applies to the Pharmaceutical Benefits Advisory Committee (PBAC) for it to be subsidised. The PBAC is an independent expert committee that reviews:

• Clinical evidence for the medicine in the proposed use
• Cost-effectiveness compared with alternatives
• The budget impact on the scheme
• The unmet clinical need

If the PBAC recommends listing, the government decides whether to accept the recommendation, often after price negotiations with the sponsor. Listings are indication-specific — meaning a medicine might be subsidised for one use but not for another, even though the medicine itself is the same.

Why listings are indication-specific

This is one of the most commonly misunderstood parts of the PBS. The same medicine can be:

• PBS-subsidised when prescribed for one condition that meets the listing criteria
• Private-script (full commercial price) when prescribed for a different condition

This isn’t arbitrary. PBAC evaluates the cost-effectiveness of a medicine in each specific use, based on the evidence in that use. A medicine might be highly cost-effective for one indication and not for another. The subsidy follows the evidence.

For patients, the practical effect is that whether your script is at the PBS or private price depends on what condition it’s being used to treat and whether you meet the listing criteria for that condition.

Standard vs Authority listings

Most PBS-subsidised medicines come under one of two structures.

Standard listings are for medicines that any authorised prescriber can prescribe under the PBS without additional approval. The prescriber writes the script, the pharmacy supplies it, and the patient pays the co-payment.

Authority listings are for medicines with stricter access rules. The prescriber needs to obtain a specific authority before the patient can access the medicine at the PBS price. This is usually done by phone or online and is granted when the patient meets the published criteria — for example, having tried other options first, having a specific severity of condition, or meeting age criteria.

Authority listings aren’t a barrier in everyday clinical practice — they’re a process, and a clinician familiar with the medicine handles them as part of the workflow. They’re a way the PBS focuses subsidy on the patients most likely to benefit, while keeping the medicine accessible for those who meet the criteria.

Co-payments and the Safety Net

The PBS has a co-payment structure — the amount the patient pays at the pharmacy for a subsidised medicine — that updates each year. There are two main co-payment rates:

• General patient rate (the standard co-payment)
• Concessional patient rate (lower co-payment for eligible concession-card holders)

If you have specific concession cards — pensioner concession card, healthcare card, veterans’ card — you pay the concessional rate.

The Safety Net is an additional protection that kicks in once a person or family has spent a certain amount on PBS medicines within a calendar year. Once you reach the threshold:

• General patients pay the concessional rate for the rest of the year
• Concessional patients pay nothing for the rest of the year

Pharmacies can track your spend with your consent so the Safety Net activates automatically once you reach the threshold. For families managing chronic conditions, this can make a meaningful difference to ongoing costs.

What this means for chronic conditions

For chronic conditions, where you’ll be picking up medicines regularly for years, a few PBS rules are particularly worth knowing.

Repeats. PBS prescriptions usually allow a number of repeats (typically up to 5), letting you supply the medicine multiple times from one script. Once the repeats run out, you’ll need a new script — usually a quick conversation with your health practitioner.

Original prescription requirements. Some medicines require the original prescription to be presented at the pharmacy, while others now use electronic prescriptions (“eScripts”) that can be supplied digitally.

Continuation rules. Some medicines have specific PBS rules around how long the listing applies — for example, time-limited authority listings that need to be re-applied for. Your prescriber handles this; you don’t need to memorise the rules.

Brand substitution. For many medicines, there’s a choice between the original brand and one or more generic versions. The active ingredient is the same; the brand and price can differ. Your pharmacist will discuss options at the counter.

Storage. Picking up a 3-month supply isn’t always possible at the PBS price — most listings are written around 1-month supplies with repeats. This isn’t usually a hassle, but it’s a small thing worth knowing.

A useful habit for ongoing care

For anyone on regular prescriptions, a few habits make managing PBS scripts easier over time:

• Use the same pharmacy where possible, so they can track your repeats and Safety Net spend
• Keep a current list of all your medicines (with doses) in one place — useful for any health professional you see
• Reorder before you run out, especially for medicines you take daily
• If something changes about the medicine — strength, brand, packaging — ask your pharmacist to explain

When the PBS doesn’t apply

Not every prescription medicine is PBS-subsidised. Reasons include:

• The medicine isn’t listed on the PBS at all (the sponsor hasn’t applied, the PBAC hasn’t recommended listing, or government hasn’t agreed to list)
• The medicine is listed but only for indications that don’t apply to your situation
• The medicine is being prescribed off-label (for a use outside its approved indications)
• The patient doesn’t meet the specific criteria for an Authority listing

In those cases, the medicine is still legally supplied — your health practitioner can prescribe it and your pharmacy can dispense it — but you pay the full private price set by the pharmacy. That price is often higher than the PBS co-payment, sometimes substantially.

A good health practitioner or pharmacist will be transparent about which scripts are PBS-subsidised and which aren’t, so there are no surprises at the counter.

The bigger picture

The PBS is one of the more unusual elements of the Australian health system in international terms — a national, government-managed subsidy scheme that focuses on medicines that have been evaluated as cost-effective. It’s not perfect, and there’s always debate about specific listings, timeframes and prices. But for anyone managing a long-term condition, it’s the single piece of infrastructure that makes regular prescriptions affordable across years and decades.

Understanding how it works — even at a high level — makes navigating ongoing prescription care a lot more predictable.